BIOMARIN PHARMA financial statements, including revenue, expenses, profit, and loss

The total revenue of BM8 for the last quarter is 584.87 M CHF, and it's 7.55% higher compared to the previous quarter. The net income of Q1 24 is 79.98 M CHF.